Compagnie Lombard Odier SCmA’s Oasmia Pharmaceutical AB OASM Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio OASM Stock Details OASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-33,300	Closed	-$33K	–	560
2019 Q2	$33K	Hold	33,300	–	–	﹤0.01%	394
2019 Q1	$76K	Hold	33,300	–	–	﹤0.01%	373
2018 Q4	$107K	Hold	33,300	–	–	﹤0.01%	324
2018 Q3	$141K	Buy	+33,300	New	+$69.7K	﹤0.01%	324

Compagnie Lombard Odier SCmA's OASM Position: Q3 2019 in Review

Compagnie Lombard Odier SCmA sold out of Oasmia Pharmaceutical AB (OASM) in Q3 2019, closing a stake of 33,300 shares — an estimated $33K sold.

Compagnie Lombard Odier SCmA first reported a position in OASM in Q3 2018 and held it in 4 quarters. The position peaked at $141K in Q3 2018. 0 funds tracked by Wall St. Rank hold OASM as of Q3 2019.

Compagnie Lombard Odier SCmA reported no remaining Oasmia Pharmaceutical AB position as of Q3 2019 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 33,300 Oasmia Pharmaceutical AB shares in Q3 2019, an estimated $33K.
Compagnie Lombard Odier SCmA first reported a position in Oasmia Pharmaceutical AB in Q3 2018 and held it in 4 quarters.
Compagnie Lombard Odier SCmA's Oasmia Pharmaceutical AB position peaked at $141K in Q3 2018.
0 funds tracked by Wall St. Rank held Oasmia Pharmaceutical AB as of Q3 2019.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2019, filed 12 Nov 2019.